Early Identification and Management of Multiple Sclerosis in Pediatric Patients
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 NIMBLE Trial: Cemdisiran Efficacy and Safety Results in gMG
2
GV101 Gains FDA Fast Track Status for Friedreich Ataxia Ahead of Phase 2 Trial
3
FDA Grants Fast Track Status to FRP-003 for Long COVID Ahead of Phase 2 Study
4
Headlining Current Advances and Challenges in Multiple Sclerosis Care
5